Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12619000805178
Ethics application status
Approved
Date submitted
27/05/2019
Date registered
3/06/2019
Date last updated
10/12/2019
Date data sharing statement initially provided
3/06/2019
Type of registration
Prospectively registered
Titles & IDs
Public title
Does timely care matter to lung cancer patients? A sub-study of the Continuous Improvement in Care – Cancer (CIC-Cancer) Project.
Query!
Scientific title
Does timely care matter to lung cancer patients? A sub-study of the Continuous Improvement in Care – Cancer (CIC-Cancer) Project.
Query!
Secondary ID [1]
298343
0
None
Query!
Universal Trial Number (UTN)
U1111-1234-1724
Query!
Trial acronym
Query!
Linked study record
The Continuous Improvement in Care - Cancer (CIC - Cancer) Project.
Principle Investigator: Professor Christobel Saunders, University of Western Australia.
Query!
Health condition
Health condition(s) or problem(s) studied:
Lung cancer
312993
0
Query!
Condition category
Condition code
Cancer
311498
311498
0
0
Query!
Lung - Non small cell
Query!
Cancer
311499
311499
0
0
Query!
Lung - Small cell
Query!
Intervention/exposure
Study type
Observational
Query!
Patient registry
False
Query!
Target follow-up duration
Query!
Target follow-up type
Query!
Description of intervention(s) / exposure
A cohort of lung cancer patients will be observed from initial abnormal CT scan all the way through until commencing treatment. Various time intervals, including referral - review and referral - treatment will be measured for each patient. At the time of treatment commencement, a patient satisfaction survey will be administered.
Patients will only be followed up until the time of their first treatment.
Query!
Intervention code [1]
314586
0
Not applicable
Query!
Comparator / control treatment
No control group.
Query!
Control group
Uncontrolled
Query!
Outcomes
Primary outcome [1]
320204
0
Patient satisfaction, as measured by the Patient Satisfaction with Cancer Care survey. This is an 18 point survey that was developed and validated in an 891 American cancer patient cohort in 2011 and covers several domains of patient satisfaction, including access to and co-ordination of care and relationships and communication with health professionals.
Reference: Jean-Pierre P, Fiscella K, Freund K et al. Structural and reliability analysis of a patient satisfaction with cancer-related care measure: A multi-site patient navigation research program study. Cancer. 2011; 117(4):854-861.
Query!
Assessment method [1]
320204
0
Query!
Timepoint [1]
320204
0
Measured within one week before or after cancer treatment commencement.
Query!
Secondary outcome [1]
370859
0
Patient perception of the timeliness of their cancer care.
Patients will be asked: “Do you feel the time from your initial referral to starting treatment has been 1 = Much too quick, 2 = A bit too quick, 3 = Just right, 4 = A bit too slow, 5 = Much too slow.”
Query!
Assessment method [1]
370859
0
Query!
Timepoint [1]
370859
0
Measured within one week before or after cancer treatment commencement.
Query!
Eligibility
Key inclusion criteria
1) Diagnosis of primary lung cancer
2) Receiving active antineoplastic therapy
3) Reviewed by the Respiratory Service at participating hospitals during the study period
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
1) Patients unable to answer survey questions
2) Patients with mesothelioma.
Query!
Study design
Purpose
Psychosocial
Query!
Duration
Longitudinal
Query!
Selection
Defined population
Query!
Timing
Prospective
Query!
Statistical methods / analysis
Data will be summarised using means (standard deviations) or medians (interquartile ranges) for continuous variables (as appropriate for the distribution) and frequency (percentages) for categorical variables. The relationship between the PSCC and timeliness of care will be considered using appropriate generalised linear models. These relationships will be estimated in isolation and following adjustment for potential confounding factors, including age, medical co-morbidities and performance status.
Query!
Recruitment
Recruitment status
Recruiting
Query!
Date of first participant enrolment
Anticipated
15/06/2019
Query!
Actual
11/10/2019
Query!
Date of last participant enrolment
Anticipated
15/06/2021
Query!
Actual
Query!
Date of last data collection
Anticipated
1/07/2021
Query!
Actual
Query!
Sample size
Target
76
Query!
Accrual to date
13
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
WA
Query!
Recruitment hospital [1]
13828
0
Royal Perth Hospital - Perth
Query!
Recruitment hospital [2]
13829
0
St John of God Midland Public Hospital - Midland
Query!
Recruitment postcode(s) [1]
26589
0
6000 - Perth
Query!
Recruitment postcode(s) [2]
26590
0
6056 - Midland
Query!
Funding & Sponsors
Funding source category [1]
302882
0
Hospital
Query!
Name [1]
302882
0
Royal Perth Hospital
Query!
Address [1]
302882
0
197 Wellington Street
Perth WA 6000
Query!
Country [1]
302882
0
Australia
Query!
Funding source category [2]
302883
0
Hospital
Query!
Name [2]
302883
0
St John of God Healthcare Midland Campus
Query!
Address [2]
302883
0
1 Clayton Street
Midland WA 6056
Query!
Country [2]
302883
0
Australia
Query!
Primary sponsor type
Hospital
Query!
Name
Respiratory Department, St John of God Healthcare
Query!
Address
St John of God Healthcare Midland Campus
1 Clayton Street
Midland WA 6056
Query!
Country
Australia
Query!
Secondary sponsor category [1]
302864
0
None
Query!
Name [1]
302864
0
Query!
Address [1]
302864
0
Query!
Country [1]
302864
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
303458
0
South Metropolitan Health Service HREC
Query!
Ethics committee address [1]
303458
0
Fiona Stanley Hospital
11 Robin Warren Drive
Murdoch WA 6150
Query!
Ethics committee country [1]
303458
0
Australia
Query!
Date submitted for ethics approval [1]
303458
0
16/05/2019
Query!
Approval date [1]
303458
0
21/05/2019
Query!
Ethics approval number [1]
303458
0
Query!
Ethics committee name [2]
304931
0
St John of God Health Care Human Research Ethics Committee
Query!
Ethics committee address [2]
304931
0
St John of God Health Care Midland Campus
1 Clayton Street
Midland WA 6056
Query!
Ethics committee country [2]
304931
0
Australia
Query!
Date submitted for ethics approval [2]
304931
0
21/07/2019
Query!
Approval date [2]
304931
0
02/09/2019
Query!
Ethics approval number [2]
304931
0
1578
Query!
Summary
Brief summary
Lung cancer is the leading cause of cancer-related mortality and morbidity in Australia, with more than 8000 Australians predicted to die in 2018 alone. Due to the poor outcomes experiences by many lung cancer patients, clinicians attempt to provide rapid review, diagnosis and treatment and adhere to the timeframes suggested in the Cancer Council’s Optimal Care Pathway. Whilst scientific end points, such as survival are important, patient reported outcomes, such as quality of life and satisfaction with care are also vital. This move towards more patient-centric care is being championed in Western Australia by the Continuous Improvement in Care – Cancer (CIC-Cancer) Project.
Are you eligible to take part in this study?
This study aims to establish if providing guideline-driven care, in terms of timeliness, improves patient satisfaction amongst people with lung cancer. You may be eligible to take part if you have primary lung cancer and are undergoing treatment and have consented to have your clinical information collected by the CIC-Cancer database.
What does the study involve?
Patients will be asked to complete an 18 question survey at the time that they start treatment for lung cancer. The survey will assess different areas of patient satisfaction with care, including access to appointments and communication with their doctor. Patients will not be obliged to any other follow up.
How will involvement in this study help patients with lung cancer?
This study will help us to validate the Cancer Council Optimal Care Pathway and ensure that striving to achieve rapid review and treatment really is making patients more satisfied with their care.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
93726
0
Dr Phoebe Brownell
Query!
Address
93726
0
St John of God Healthcare Midland Campus
1 Clayton Street
Midland WA 6056
Query!
Country
93726
0
Australia
Query!
Phone
93726
0
+61 411618742
Query!
Fax
93726
0
Query!
Email
93726
0
[email protected]
Query!
Contact person for public queries
Name
93727
0
Dr Phoebe Brownell
Query!
Address
93727
0
St John of God Healthcare Midland Campus
1 Clayton Street
Midland WA 6056
Query!
Country
93727
0
Australia
Query!
Phone
93727
0
+61 411618742
Query!
Fax
93727
0
Query!
Email
93727
0
[email protected]
Query!
Contact person for scientific queries
Name
93728
0
Dr Phoebe Brownell
Query!
Address
93728
0
St John of God Healthcare Midland Campus
1 Clayton Street
Midland WA 6056
Query!
Country
93728
0
Australia
Query!
Phone
93728
0
+61 411618742
Query!
Fax
93728
0
Query!
Email
93728
0
[email protected]
Query!
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
Yes
Query!
What data in particular will be shared?
Only responses to the PSCC survey will be shared.
All other patient information is at the discretion of the CIC-Cancer database.
Query!
When will data be available (start and end dates)?
Starting at the end of data collection.
Data will be available for 7 years.
Query!
Available to whom?
Anyone who wishes to access.
Query!
Available for what types of analyses?
Any type of analysis.
Query!
How or where can data be obtained?
By approval from the Principle Investigator.
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Doc. No.
Type
Citation
Link
Email
Other Details
Attachment
2198
Study protocol
377667-(Uploaded-27-05-2019-22-54-39)-Study-related document.docx
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF